Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Invention Grant

US10793894B2 Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition 有权

Please log in to see more content

Patent Title: Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
Application No.: US16280913

Application Date: 2019-02-20
Publication No.: US10793894B2

Publication Date: 2020-10-06
Inventor: Brett E. Crawford , Jillian R. Brown , Charles A. Glass , Jim R. Beitel , Robin M. Jackman
Applicant: BIOMARIN PHARMACEUTICAL INC.
Applicant Address: US CA Novato
Assignee: BIOMARIN PHARMACEUTICAL INC.
Current Assignee: BIOMARIN PHARMACEUTICAL INC.
Current Assignee Address: US CA Novato
Agency: Jones Day
Main IPC: C12Q1/34
IPC: C12Q1/34 ; C12Q1/527 ; C12Q1/40 ; G01N33/68

Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition

Abstract:

Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.

Public/Granted literature

US20190249224A1 QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION Public/Granted day:2019-08-15

Information query

Espacenet

IPC分类:

C	化学；冶金
C12	生物化学；啤酒；烈性酒；果汁酒；醋；微生物学；酶学；突变或遗传工程
C12Q	包含酶、核酸或微生物的测定或检验方法（免疫检测入G01N33/53）；其所用的组合物或试纸；这种组合物的制备方法；在微生物学方法或酶学方法中的条件反应控制
C12Q1/00	包含酶、核酸或微生物的测定或检验方法（带有条件测量或传感器的测定或试验装置，如菌落计数器入C12M1/34）；其组合物；这种组合物的制备方法
C12Q1/34	.包括水解酶